JP2015520744A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520744A5 JP2015520744A5 JP2015510500A JP2015510500A JP2015520744A5 JP 2015520744 A5 JP2015520744 A5 JP 2015520744A5 JP 2015510500 A JP2015510500 A JP 2015510500A JP 2015510500 A JP2015510500 A JP 2015510500A JP 2015520744 A5 JP2015520744 A5 JP 2015520744A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disease
- cancer
- composition according
- cxcl17
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 201000010099 disease Diseases 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 3
- 210000004072 lung Anatomy 0.000 claims 3
- 102100039435 C-X-C motif chemokine 17 Human genes 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 2
- 208000015943 Coeliac disease Diseases 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010041067 Small cell lung cancer Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000025865 Ulcer Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 208000026935 allergic disease Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 2
- 230000009610 hypersensitivity Effects 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 208000028774 intestinal disease Diseases 0.000 claims 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- 201000004071 non-specific interstitial pneumonia Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 201000010727 rectal prolapse Diseases 0.000 claims 2
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- 231100000397 ulcer Toxicity 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010019375 Helicobacter infections Diseases 0.000 claims 1
- 241000590002 Helicobacter pylori Species 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 108091005461 Nucleic proteins Proteins 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 210000003128 head Anatomy 0.000 claims 1
- 229940037467 helicobacter pylori Drugs 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 210000003739 neck Anatomy 0.000 claims 1
- 208000025440 neoplasm of neck Diseases 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 210000000496 pancreas Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 210000003932 urinary bladder Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261642209P | 2012-05-03 | 2012-05-03 | |
| US61/642,209 | 2012-05-03 | ||
| PCT/US2013/039586 WO2013166470A2 (en) | 2012-05-03 | 2013-05-03 | Uses of cxcl17, a novel chemokine marker of human lung and gastrointestinal disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015520744A JP2015520744A (ja) | 2015-07-23 |
| JP2015520744A5 true JP2015520744A5 (enExample) | 2016-11-24 |
Family
ID=49515050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015510500A Pending JP2015520744A (ja) | 2012-05-03 | 2013-05-03 | ヒトの肺疾患および胃腸管系疾患の新規ケモカインマーカーであるｃｘｃｌ１７の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150140008A1 (enExample) |
| EP (1) | EP2866832A4 (enExample) |
| JP (1) | JP2015520744A (enExample) |
| AU (1) | AU2013256050A1 (enExample) |
| CA (1) | CA2871671A1 (enExample) |
| MX (1) | MX2014013380A (enExample) |
| WO (1) | WO2013166470A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2925050A1 (en) * | 2013-09-30 | 2015-04-02 | The Regents Of The University Of California | Identification of cxcr8, a novel chemokine receptor |
| US20210277102A1 (en) * | 2016-08-30 | 2021-09-09 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods for treating a tumor suppressor deficient cancer |
| TR201811691A2 (tr) * | 2018-08-10 | 2018-09-21 | Hacettepe Ueniversitesi | Cxcl17 ami̇no ucu öncül di̇zi̇si̇nden türevlenen i̇mmünmodülatör pepti̇t |
| WO2025007057A2 (en) * | 2023-06-29 | 2025-01-02 | The Board Of Trustees Of The Leland Stanford Junior University | Lymphocyte trafficking receptor and ligand |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US20030232367A1 (en) * | 2002-04-12 | 2003-12-18 | Weinstein Edward J. | Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| AU2003273233A1 (en) * | 2002-08-19 | 2004-03-03 | Pharmacia Corporation | Antisense modulation of vegf co-regulated chemokine-1 expression |
-
2013
- 2013-05-03 EP EP13785069.9A patent/EP2866832A4/en not_active Withdrawn
- 2013-05-03 JP JP2015510500A patent/JP2015520744A/ja active Pending
- 2013-05-03 CA CA2871671A patent/CA2871671A1/en not_active Abandoned
- 2013-05-03 US US14/398,053 patent/US20150140008A1/en not_active Abandoned
- 2013-05-03 MX MX2014013380A patent/MX2014013380A/es unknown
- 2013-05-03 AU AU2013256050A patent/AU2013256050A1/en not_active Abandoned
- 2013-05-03 WO PCT/US2013/039586 patent/WO2013166470A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boyapati et al. | Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications | |
| Bergström et al. | Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs | |
| JP2017516775A5 (enExample) | ||
| JP2015520744A5 (enExample) | ||
| JP2016527221A5 (enExample) | ||
| JP2016536330A5 (enExample) | ||
| JP2015529329A5 (enExample) | ||
| JP2017530372A5 (enExample) | ||
| JP2016528914A5 (enExample) | ||
| JP2015530094A5 (enExample) | ||
| JP2019521312A5 (enExample) | ||
| JP2016515123A5 (enExample) | ||
| JP2019504860A5 (enExample) | ||
| HRP20191874T1 (hr) | N-[2-2-{4-[6-amino-5-(2,4-difluorobenzoil)-2-oksopiridin-1(2h)-il]-3,5-difluorofenil}etil]-l-alanin i njegov terbutil ester | |
| HRP20150470T1 (hr) | Topljivi icam-1 kao biomarker za predviđanje terapijskog odgovora | |
| JP2015194481A5 (enExample) | ||
| 莊志堅 et al. | Horseshoe Kidney in Meckel's Diverticulum Scan Mimicking Gastrointestinal Tract Bleeding | |
| ZhiYin et al. | Changes in gastrointestinal structure and function caused by cirrhotic portal hypertension and related clinical manifestations | |
| EA201992378A1 (ru) | Белки для лечения дисфункций эпителиального барьера | |
| Alyavi et al. | The Clinical Role of Nitric Oxide and L-arginine in Asthma. | |
| Cinar et al. | A72 MECHANISMS DRIVING FIBROSIS: Novel Treatment Strategy For Pulmonary Fibrosis By A Hybrid Inhibitor Of Peripheral Cannabinoid-1-Receptors (cb1r) And Inducible No Synthase (INOS) | |
| KIM et al. | HGF-mediated Stabilization of Blood Retinal Barrier in Developing Retina | |
| Hurdman et al. | B108 DIAGNOSTIC AND PROGNOSTIC ASSESSMENT OF PULMONARY VASCULAR DISEASE: The Utility Of Incremental Shuttle Walking Test In Pulmonary Hypertension | |
| JP2012210167A5 (enExample) | ||
| Amano | Editorial Comment from Dr Amano to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation |